Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
28: ASCO 2026: Practice-Guiding Updates in Bladder and Kidney Cancer
|
Jun 25, 2026 |
|
27: ASCO 2026: Translating the Top Prostate Cancer Data Into Clinical Action
|
Jun 11, 2026 |
|
26: Optimizing Therapeutic Strategies Across the NMIBC Paradigm
|
May 14, 2026 |
|
25: What Role Will The EV-304 Regimen Occupy in The Bladder Cancer Paradigm?
|
Apr 16, 2026 |
|
24: How Will Data From ASCO GU 2026 Impact the Treatment Paradigm?
|
Mar 26, 2026 |
|
23: Decoding Key Community Oncology Takeaways From ASCO GI 2026
|
Feb 26, 2026 |
|
22: International Perspectives in Prostate Cancer: A Look at Treatment in India
|
Feb 19, 2026 |
|
21: Decoding the Top Moments in Prostate Cancer From 2025
|
Jan 22, 2026 |
|
20: What Were The Key Kidney and Bladder Cancer Advances in 2025?
|
Jan 08, 2026 |
|
19: How to Manage Oligometastatic Kidney Cancer? Insights From IKCS 2025
|
Dec 04, 2025 |
|
18: What Were The Most Impactful GU Oncology Data From ESMO 2025?
|
Nov 06, 2025 |
|
17: Exploring the ESMO 2025 Presentations That May Shift GU Oncology
|
Oct 16, 2025 |
|
16: Diving Into the Practical Applications of ctDNA in Oncology Care
|
Sep 25, 2025 |
|
15: Gathering the Latest Multidisciplinary Care Insights Across World GU 2025
|
Sep 18, 2025 |
|
14: Elevating Community Oncology Care: Insights From World GU 2025
|
Sep 12, 2025 |
|
13: Optimizing Care Planning for Variant Histology Populations at World GU 2025
|
Sep 11, 2025 |
|
12: Beyond the BEP: A Deep Dive into Testicular Cancer Management
|
Aug 28, 2025 |
|
11: Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma
|
Aug 14, 2025 |
|
10: Navigating Second-Line Treatment Options in Urothelial Carcinoma
|
Jul 31, 2025 |
|
9: Unveiling Advances in GU Cancers: Insights from Oncology Decoded
|
Jul 03, 2025 |
|
8: ASCO 2025 Debrief: Key Updates in Genitourinary Cancer Management
|
Jun 19, 2025 |
|
7: Sharpening the Prostate Cancer Toolkit: Practical Insights on PSMA Imaging
|
Jun 05, 2025 |
|
6: A Sneak Peek at 2025 ASCO From the GU Perspective
|
May 15, 2025 |
|
5: Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer
|
May 01, 2025 |
|
4: Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer
|
Apr 01, 2025 |
|
3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma
|
Mar 07, 2025 |
|
2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
|
Mar 05, 2025 |
|
1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer
|
Mar 04, 2025 |